| Name | novobiocin |
|---|---|
| Synonyms |
NOVOBIOCIN
benzamide,n-(7-((3-o-(aminocbonyl)-6-deoxy-5-c-methyl-4-o-methyl-beta-l-lyxo inamycin Benzamide, N-[7-[[3-O-(aminocbonyl)-6-deoxy-5-C-methyl-4-O-methyl-α-L-lyxo-hexopyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-(3-methyl-2-buten-1-yl) spheromycin Novobiocin powder NOVOBIOCIN, STANDD cdelmycin crystallinicacid novo-r cathomycin hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2h-1-benzopyran-3-yl)-4-hydroxy AlbaMycin, VulcaMycin, PA 93, WS 6629, iseoflavin, S 800 antibiotia-93 albamix Novobiocin 1000 μg/mL in Acetonitrile sirbiocina 3-(3-methyl-2-butenyl) NOVOBIOCIN H0D3271012UG/MG(DR) Novobiocin //BP 7-[4'-(Cbamoyloxy)-tetrahydro-3'-hydroxy-5'-methoxy-6',6'-dimethylpyran-2'-yloxy]-4-hydroxy-3-[4''-hydroxy (3''-methyl-2''-butenyl)-benzamide]-8-methylcoumin C05080 Novobiocin in methanol robiocina stilbiocina Notonesomycin (3R,4S,5R,6R)-5-Hydroxy-6-[(2-hydroxy-3-{[4-hydroxy-3-(3-methyl-2-buten-1-yl)benzoyl]amino}-8-methyl-4-oxo-4H-chromen-7-yl)oxy]-3-methoxy-2,2-dimethyltetrahydro-2H-pyran-4-yl carbamate (non-preferred name) cathocin (3R,4S,5R,6R)-5-Hydroxy-6-((4-hydroxy-3-(4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamido)-8-methyl-2-oxo-2H-chromen-7-yl)oxy)-3-methoxy-2,2-dimethyltetrahydro-2H-pyran-4-yl cbamate pa93 |
| Description | Novobiocin (Albamycin) is a potent and orally active antibiotic. Novobiocin also is a DNA gyrase inhibitor and a heat shock protein 90 (Hsp90) antagonist. Novobiocin has the potential for the research of highly beta-lactam-resistant pneumococcal infections. Novobiocin shows anti-orthopoxvirus activity[1][2][3][4][6]. |
|---|---|
| Related Catalog | |
| Target |
HSP90 |
| In Vitro | Novobiocin (1 mM) competitively inhibits ATP binding to gyrase B to interfere with nucleotide binding and interferes with the association of the co-chaperones Hsc70 and p23 with Hsp90[1]. Novobiocin (200 µM; 24 h) inhibits the rate of repair of both cis-DDP and BCNU induced DNA interstrand cross-links and with a corresponding decrease in the clonogenic survival of the human glioblastoma multiforme cells[2]. Novobiocin (0.3 mM; 48 hours) induces a caspase-3/7 enzyme–dependent apoptosis assays with an induction of approximately three- to fivefold of apoptotic cells in K562, HL60, Mutz-2[5]. |
| In Vivo | Novobiocin (25, 50, 100, 200 mg/kg; s.c.; 4 times at 1, 5, 24 and 48 h after infection) shows anti-infection activity in mice infected with amoxicillin-resistant Streptococcus pneumoniae[3]. Animal Model: 30 g adult female Swiss mice (sepsis induced by the penicillin-susceptible strain (AR33118))[3] Dosage: 25, 50, 100, 200 mg/kg Administration: S.c.; given at 1, 5, 24 and 48 h after infection Result: Showed anti-infection activity in mice infected with amoxicillin-resistant S. pneumoniae. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 848.2±65.0 °C at 760 mmHg |
| Melting Point | 170-172°C (lit.) |
| Molecular Formula | C31H36N2O11 |
| Molecular Weight | 612.624 |
| Flash Point | 466.8±34.3 °C |
| Exact Mass | 612.231934 |
| PSA | 200.01000 |
| LogP | 2.37 |
| Vapour Pressure | 0.0±3.3 mmHg at 25°C |
| Index of Refraction | 1.640 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302-H317 |
| Precautionary Statements | P280-P301 + P312 + P330 |
| Hazard Codes | Xi |
| RIDADR | NONH for all modes of transport |
| Precursor 2 | |
|---|---|
| DownStream 1 | |